1. Home
  2. CPHI vs GRNQ Comparison

CPHI vs GRNQ Comparison

Compare CPHI & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$0.61

Market Cap

31.2M

Sector

Health Care

ML Signal

HOLD

Logo Greenpro Capital Corp.

GRNQ

Greenpro Capital Corp.

HOLD

Current Price

$1.44

Market Cap

29.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPHI
GRNQ
Founded
N/A
2013
Country
China
Malaysia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
31.2M
29.6M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
CPHI
GRNQ
Price
$0.61
$1.44
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.5M
14.8K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,144,268.00
$3,673,997.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.55
52 Week Low
$0.38
$1.21
52 Week High
$2.00
$3.18

Technical Indicators

Market Signals
Indicator
CPHI
GRNQ
Relative Strength Index (RSI) 41.41 39.47
Support Level $0.52 $1.30
Resistance Level $0.68 $1.83
Average True Range (ATR) 0.12 0.07
MACD -0.01 0.00
Stochastic Oscillator 11.20 12.91

Price Performance

Historical Comparison
CPHI
GRNQ

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China, and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust, & wealth management. Its segments include the Service business engaged in the provision of corporate advisory & business solution services; the Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong & Malaysia; & the Digital business segment engaged in the provision of digital platform & trading of digital assets.

Share on Social Networks: